Literature DB >> 7287217

In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases.

A Mantovani.   

Abstract

Macrophages were isolated by adherence from an early-passage chemically-induced tumor in C57BL/6 mice and from its spontaneous lung metastases. Cytolytic activity was measured as release of [3H]-thymidine from prelabelled tumor cells and cytostasis in a postlabelling assay. Normal, unstimulated peritoneal macrophages exhibited low but significant non-specific cytotoxic activity at attacker to target (A:T) ratios greater than or equal to 20:1, whereas stimulation of tumor-cell proliferative capacity was consistently observed at A:T ratios less than or equal to 2.1, Macrophages from the peritoneal cavity of tumor-bearing mice, from the primary tumor or from polled secondaries had baseline cytotoxic or growth-enhancing (depending on the A:T ratio) potential similar to that of control peritoneal macrophages. In vitro exposure to endotoxin, lymphokine supernatants or partially purified fibroblast interferon augmented the tumoricidal activity of normal and tumor-associated macrophages; tumor-associated macrophages showed no evidence of enhanced responsiveness to these activating stimuli. Tumor cells from the primary neoplasm and its spontaneous metastases were equally susceptible to macrophage tumoricidal activity. It is inferred from in vitro data that the relatively low numbers of non-activated macrophages present within poorly immunogenic metastasizing tumors may have no direct effect or actually stimulate tumor-cell proliferative capacity at the primary tumor site; conversely, disseminating tumor cells might encounter sufficient numbers of mononuclear phagocytes in the circulation and in lungs to permit the expression of macrophage cytotoxicity, at least during the early steps of metastasis formation.

Entities:  

Mesh:

Year:  1981        PMID: 7287217     DOI: 10.1002/ijc.2910270215

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

Authors:  R P Negus; G W Stamp; J Hadley; F R Balkwill
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Ia antigen expression and IL-1 activity in murine tumour-associated macrophages.

Authors:  G Peri; V Rossi; G Taraboletti; A Erroi; A Mantovani
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

4.  Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients.

Authors:  B Sheid; J Boyce
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 5.  Macrophages in cancer metastases and their relevance to metastatic growth.

Authors:  M E Key
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.

Authors:  J L Urban; H Schreiber
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.